Mathematical Modeling and Experimental Validation of Nanoemulsion-Based Drug Transport across Cellular Barriers

Abstract

Purpose Nanoemulsions have shown potential in delivering drug across epithelial and endothelial cell barriers, which express efflux transporters. However, their transport mechanisms are not entirely understood. Our goal was to investigate the cellular permeability of nanoemulsion-encapsulated drugs and apply mathematical modeling to elucidate transport mechanisms and sensitive nanoemulsion attributes. Methods Transport studies were performed in Caco-2 cells, using fish oil nanoemulsions and a model substrate, rhodamine-123. Permeability data was modeled using a semi-mechanistic approach, capturing the following cellular processes: endocytotic uptake of the nanoemulsion, release of rhodamine-123 from the nanoemulsion, efflux and passive permeability of rhodamine-123 in aqueous solution. Results Nanoemulsions not only improved the permeability of rhodamine-123, but were also less sensitive to efflux transporters. The model captured bidirectional permeability results and identified sensitive processes, such as the release of the nanoemulsion-encapsulated drug and cellular uptake of the nanoemulsion. Conclusions Mathematical description of cellular processes, improved our understanding of transport mechanisms, such as nanoemulsions don’t inhibit efflux to improve drug permeability. Instead, their endocytotic uptake, results in higher intracellular drug concentrations, thereby increasing the concentration gradient and transcellular permeability across biological barriers. Modeling results indicated optimizing nanoemulsion attributes like the droplet size and intracellular drug release rate, may further improve drug permeability.

Development and Comparative In Vitro and In Vivo Study of BNN27 Mucoadhesive Liposomes and Nanoemulsions for Nose-to-Brain Delivery

“…This fact can be attributed to the adhesion of the CHT LIPs or NE droplets to the monolayer, resulting in delayed permeability. Free RHO (micellar solution) did not show any difference compared to LIP-RHO (not shown), while compared to the NEs, its permeability was significantly lower, which is in good agreement with the previously reported results [ 40 ].…”

Discovery of novel N‐aryl pyrrothine derivatives as bacterial RNA polymerase inhibitors

“…Moreover, the activities here were much lower than those based on the in vivo antibacterial assay (Table 3), indicating that these selected compounds might inhibit the bacterial growth through some other mechanisms in addition to the RNAP inhibition. In summary, the weaker antibacterial activity against Gram‐negative bacteria than Gram‐positive bacteria for these compounds might be due to the difference in cellular‐uptake barriers and efflux (Kadakia, Shah, & Amiji, 2017), and the selected synthesized compounds might bind to different sites of E. coli RNAP from that of rifampin. Further studies are needed to reveal the exact mechanism of action.…”

Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth

“…Preparation of nanoemulsion formulations was carried out as reported previously with some modifications (25). Instead of a sonication method, oil-in-water nanoemulsions were prepared by high pressure homogenization method.…”